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Patients with multiple cholesterol gallbladder 
stones have been found to be at a higher risk for the 
recurrence of gallstones after successful nonsurgical 
treatment than those with a solitary stone. Cholesterol 
gallstone recurrence, like primary gallstone for- 
mation, probably involves a triple defect with super- 
saturation, abnormally rapid nucleation of cholesterol 
in bile and altered gallbladder motor function. We 
investigated whether the increased recurrence rate of 
patients with multiple stones might be caused by more 
rapid nucleation. Therefore the time required for 
cholesterol monohydrate crystals to appear in ultra- 
centrifuged bile of patients with solitary (n = 71) or 
multiple (n = 42) cholesterol gallstones was deter- 
mined. 
The cholesterol nucleation time was significantly 
(p < 0.01) longer in the bile from patients with solitary 
stones (< 1 to 16 days, median = 2.0 days) than in the 
bile from patients with multiple stones ( < 1 to 8 days, 
median = 1.0 days). Moreover, 15 of 71 (21.1%) patients 
with solitary cholesterol stones but only 1 of 42 (2.4%) 
patients with multiple cholesterol stones showed a 
normal ( > 4 days) nucleation time. 
However, no difference in the cholesterol saturation 
index was found between the bile samples from pa- 
tients with solitary stones and the bile samples from 
patients with multiple stones (1.55 2 0.65 vs. 1.54 -+ 
0.59, mean 2 S.D., respectively). The more rapid cho- 
lesterol nucleation in gallbladder bile may, therefore, 
be the major risk factor causing the higher percentage 
of stone recurrence in patients with multiple choles- 
terol stones as compared with patients with solitary 
cholesterol stones. (HEPATOLOGY 1992; 15:804-808.) 
The recurrence of cholesterol gallstones, like primary 
gallbladder stone formation, probably involves a triple 
defect with cholesterol supersaturation, abnormally 
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rapid nucleation and impaired gallbladder motor 
function (1-6). 
Recurrence rates of 30% to 61% over 3 to 12 yr have 
been reported after successful nonsurgical treatment of 
gallstones (7-10). The recurrence rate increases about 
10% a year, and after 3 to 5 yr a plateau with no further 
recurrences is usually seen (7, 8). Multiple gallstones 
seem to recur more often than solitary stones (9). The 
mechanism underlying this observation is unclear but 
might be related to different nucleation times in gall- 
bladder bile. Therefore we measured cholesterol nucle- 
ation time in the gallbladder bile of patients with 
multiple or solitary cholesterol gallstones to test 
whether the increased risk of patients with multiple 
stones is caused by more rapid nucleation. 
MATERIALS AND METHODS 
Patients and Collection of Bile Samples. A total of 113 
patients, 85 women and 28 men, who underwent elective 
cholecystectomy because of symptomatic gallstone disease 
were included in the study. A total of 71 patients (51 women 
and 20 men) had a solitary gallbladder stone with a cholesterol 
content above 50%, and 42 patients (34 women and 8 men) had 
multiple stones with a cholesterol content above 50%. Twelve 
patients with dilute gallbladder bile (total lipid concentration 
(TLC) < 1.0 gm/dl) and suspected cystic duct obstruction were 
excluded from the study. During surgery bile was aspirated 
from the gallbladder with an 18-gauge needle soon after 
ligation of the cystic duct. Particular care was taken to collect 
gallbladder bile completely. Because of the known stratifi- 
cation of human gallbladder bile (1 11, only complete aspiration 
of bile can provide valid samples. The clamping of the 
gallbladder wall before bile aspiration was avoided to prevent 
mucosal damage. Stones were removed with the gallbladder, 
washed with distilled water, dried and weighed. The choles- 
terol content of the stones was measured chemically after 
extraction with organic solvents and was expressed as per- 
centage of dry weight (12). 
Cholesterol Nucleation Time. After collection bile samples 
were mixed thoroughly, and one drop was immediately 
examined by polarized light microscopy for cholesterol 
crystals. 
For the determination of cholesterol nucleation time, 
4 ml of gallbladder bile was centrifuged at  37" C for 1 hr  at  
100,000 g in a Beckman L-50 ultracentrifuge (Beckman 
Instruments, Fullerton, CA) to obtain crystal-free bile as 
described by Holan et al. (3). The top 1 ml was discarded, and 
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TABLE 1. Concentrations of bile acids, phospholipids, 
cholesterol, total lipids and the CSI in 17 gallbladder bile 
samples from patients with cholesterol gallstones after 
ultracentrifugation and after ultrafiltration 
(Millex 0.22-pm filter) 
Gallbladder bile samples 
ultracentrifugation ultrafiltration 
After After 
~ ~ ~~~ 
Bile acids (mmoliL) 111.9 2 61.4 74.4 -t 45.0" 
Phospholipids (mmol/L) 38.2 t 23.6 21.0 ? 14.9" 
Cholesterol (mmol/L) 16.9 t 9.4 8.4 2 5.9" 
Total lipids (gmidl) 9.2 * 5.2 5.4 t 3.6" 
CSI 1.52 ? 0.48 1.32 2 0.41 
All numbers mean ? S.D. 
"p < 0.001. 
3 . o  
0 
the next 2 ml (interphase) was removed by aspiration. Cultures 
of the native bile were examined for bacterial growth. In 
addition, 10 ~1 of 20% sodium wide was added t o  1.0 ml bile 
aliquots (interphase) to prevent bacterial growth during 
incubation. An aliquot of the interphase was immediately 
examined microscopically to confirm the absence of crystals; 
the rest was placed in sterile tubes, flushed with nitrogen, 
sealed and incubated at 37" C. The interphase was investigated 
daily for the appearance of cholesterol crystals. 
The interval between time zero and the first detection of a 
cholesterol crystal in the sample was taken as the nucleation 
time. In accordance with Holan et al. (3) a discriminating point 
in time at 4 days was chosen to differentiate between normal 
(>4 days) and abnormal (54 days) nucleation time of 
cholesterol in bile. 
For the sake of comparison, additional determinations of 
cholesterol nucleation time were performed in 17 selected 
samples of gallbladder bile from patients with cholesterol 
stones using the method described by van Erpecum et al. (13). 
These authors used ultrafiltration with 0.22-km Millex filters 
(Millipore, Molsheim, France) instead of ultracentrifugation to 
remove cholesterol crystals from the bile samples. In the 17 
patients nucleation times in the bile samples after ultrafil- 
tration were about threefold to fourfold longer than in 
ultracentrifuged bile samples (Fig. 1). As shown in Table 1 a 
highly significant decrease of the main biliary lipids (bile acids, 
phospholipids and cholesterol) was found in ultrafiltered as 
compared with ultracentrifuged bile samples. These results 
demonstrate that ultrafiltration of gallbladder bile even 
through large pore-sized membranes may alter the compo- 
sition of bile, leading to a prolongation of cholesterol nucle- 
ation time. We therefore used ultracentrifugation instead of 
ultrafiltration in our study to remove cholesterol crystals from 
the bile samples before the nucleation assay. 
Analysis of Biliary Lipids. For the analysis of biliary lipids, 
duplicate aliquots were stored at - 70" C before determina- 
tion. Cholesterol was determined colorimetrically with the 
Liebermann-Burchard reaction after the extraction of a 1-ml 
methanolic bile sample using petroleum ether (14). Phospho- 
lipids were measured as total biliary phosphate after hy- 
drolysis at 150" C with sulfuric acid using the colorimetric 
assay of Fiske and Subbarow (15). Inorganic phosphate is only 
a trace constituent of total biliary phosphate; therefore total 
phosphate adequately reflects lipid-bound phosphate. Total 
bile salts were determined by a modified 3-a-hydroxysteroid 
dehydrogenase method (16). 
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FIG. 1. Relation of cholesterol nucleation time (logarithmic scale) 
after ultracentrifugation and after ultrafiltration of gallbladder bile 
from 11 patients with solitary (0) and 6 patients with multiple (0 )  
cholesterol stones. 
The cholesterol saturation index (CSI) of each sample was 
calculated by dividing the cholesterol concentration by the 
maximum cholesterol solubility according to Carey (17) and 
corrected for the total lipid content of each individual bile 
sample. 
Statistical Analysis. Student's t test was used for para- 
metric data and the Mann-Whitney U test was applied for 
nonparametric data (nucleation time). Nonparametric corre- 
lation was performed by Spearman's rank correlation coeffi- 
cient. The level of statistical significance was set at p 5 0.05. 
RESULTS 
The concentrations of bile acids, phospholipids, cho- 
lesterol, total lipids, CSI and the cholesterol nucleation 
time in the different groups of patients are shown in 
Table 2. In the bile of patients with solitary or multiple 
cholesterol gallstones, similar concentrations of the 
biliary lipids and the CSI values were determined. 
However, the cholesterol nucleation time was signifi- 
cantly (p < 0.01) longer in the bile samples of patients 
with solitary cholesterol gallstones than in the bile 
samples of patients with multiple cholesterol gallstones 
(Table 2). Only 1 (2.4%) of 42 patients with multiple 
cholesterol gallstones but 15 (21.1%) of 71 patients with 
solitary cholesterol gallstones showed a normal ( > 4 
days) nucleation time (Fig. 2A, B) in the bile samples. No 
correlation was found between the cholesterol nucle- 
ation time and the CSI in both groups of patients (Fig. 
2A, B). Indeed, in some bile samples the CSI demon- 
strated apparent undersaturation with cholesterol, yet 
an abnormally rapid nucleation of cholesterol was 
determined (Fig. 2A, B). 
Dilute bile samples, as expected, showed higher CSI 
values than more concentrated bile samples, and a 
significant (p < 0.02) negative correlation between TLC 
and CSI was seen in gallbladder bile samples of both 
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FIG. 2.  Relation of cholesterol nucleation time (logarithmic scale) 
and CSI in the gallbradder bile samples from 71 patients with (A) 
solitary (0) and 42 patients with (B) multiple (0)  cholesterol stones. 
patients with solitary and multiple cholesterol stones 
(Fig. 3A, B). Despite this finding, the cholesterol nucle- 
ation times in dilute ( < 5 gmfdl TLC) bile samples ( < 1 
to 16 days, median = 2.0 days) tended to be even longer 
than in more concentrated ( > 5 gm/dl TLC) bile samples 
(< 1 to 9 days, median = 1.5 days), but no correlation 
between the single values of TLC and cholesterol 
nucleation time in bile samples was obtained (data not 
shown). 
DISCUSSION 
In a recent study by Villanova et al. (9) solitary 
gallbladder stones were found to have less tendency to 
TABLE 2. Concentration of bile acids, phospholipids, 
cholesterol, total lipids and CSI and cholesterol nucleation 
time in gallbladder bile samples from 71 patients with 
solitary cholesterol gallstones and 42 patients with multiple 
cholesterol gallstones 
~ ~ 
Gallbladder bile samples 
Patients Patients 
with solitary with multiple 
cholesterol stones cholesterol stones 
(n = 71) (n = 42) 
~~ ~~ 
Bile acids (mmol/L) 79.2 ? 42.1 75.1 2 46 3 
Phospholipids (mmoVL) 29.6 2 18.4 28.1 & 18.9 
11.4 t 7.6 Cholesterol (mmol/L) 12.2 2 5.9 
Total lipids (gm,ldl) 6.7 ? 3.4 6.4 t 3.8 
CSI 1.55 ? C.65 1.54 t 0.59 
Nucleation time (days) 2.0 (median)" 1.0 (median)' 
All numbers mean ? S.D. 
"Range = less than 1 day up to 16 days. 
'Range = less than 1 day up to 8 days; p < 0.01. 
recur after successful medical treatment than multiple 
stones. In an attempt to explain the pathogenetic factors 
responsible for the higher recurrence rate of multiple 
gallbladder stones, we compared cholesterol saturation 
and the cholesterol nucleation time in bile samples of 71 
patients with solitary gallstones and 42 patients with 
multiple gallstones. No differences in cholesterol satu- 
ration were found between bile samples from patients 
with solitary stones and bile samples from patients with 
multiple stones. Nucleation time, however, was signifi- 
cantly shorter in bile samples with multiple cholesterol 
stones than in bile samples with solitary gallbladder 
stones. Only 1 of 42 patients with multiple stones as 
compared with 15 of 71 patients with a single stone had 
a normal nucleation time ( > 4 days). On the other hand, 
a rapid nucleation time of 1 day and less was observed in 
only 35% of patients with solitary cholesterol stones 
compared with 50% of patients with multiple cholesterol 
stones. These rates are very similar to the percentage of 
long-term stone recurrence after successful dissolution 
with oral bile acids. These observations suggest that an 
abnormally rapid nucleation of cholesterol in gallbladder 
bile is associated with a high rate of stone recurrence. 
Although our results confirm in a larger group of 
patients earlier observations by Gollish et al. (18), our 
findings show marked differences compared with a study 
by van Erpewm et al. (13). The latter group observed 
longer nucleation times both in a group of 45 patients 
with multiple cholesterol stones (1 to more than 21 days; 
median = 4.0 days) and in 22 patients with solitary 
cholesterol stones (2 to more than 21 days; median = 21 
days). This clear discrepancy may be the result of the 
difference in inethods used in performing the cholesterol 
nucleation assay. In place of ultracentrifugation as 
originally described by Holan et al. (3) and as used by 
Gollish et al. (18) and ourselves, van Erpecum et al. (13) 
used ultrafiltration with 0.22-pm Millex filters to  
remove cholesterol crystals from bile. As shown in Table 
1 we found a significant decrease in all types of biliary 
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lipids after ultrafiltration (bile acids, phospholipids and 
cholesterol), which led to a slight decline in the CSI and 
obviously to a prolonged nucleation time in ultrafiltered 
as compared with ultracentrifuged bile samples. Con- 
ceivably, the used filters retain cholesterol-phospholipid 
vesicles and mixed micellar lipid aggregates. 
The retention of bile lipids by a 0.22-pm filter has not 
been reported by Pattinson and Willis (19) and Whiting 
and Watts (20). Pattinson and Willis (19) compared 
filtered and ultracentrifuged bile in only 4 of a total of 11 
bile samples because, as a result of high mucus content, 
ultrafiltration did not yield sufficient bile in 7 samples. 
The data on 4 of the 11 samples may therefore not be 
representative. Nevertheless, Pattinson and Willis (19) 
confirmed that the cholesterol nucleation time in ul- 
trafiltered bile is consistently prolonged compared with 
ultracentrifuged bile (9.3 ? 3.7 days vs. 2.9 & 0.4 days) 
as has been shown in our study. In the study by Whiting 
and Watts (20) no data are given. 
Groen et al. (21), using concanavalin A-Sepharose 
chromatography of gallbladder bile, isolated a glucose- 
containing and mannose-containing 130-kD glyco- 
protein with strong cholesterol nucleation-promoting 
activity in model bile samples. This glycoprotein was 
found in most gallbladder bile samples, but much higher 
nucleation-promoting activity titers were observed in 
bile samples from patients with multiple cholesterol 
stones than in bile samples from patients with solitary 
stones. It is tempting to speculate that this observation 
could partially explain the differences in cholesterol 
nucleation time in the gallbladder bile samples of 
patients with solitary gallstones and multiple gallstones 
found in our study. 
Cholesterol supersaturation of bile is thought to be 
the prerequisite for gallstone formation (1,2). However, 
in our study some patients with apparent cholesterol 
undersaturation showed clearly abnormal nucleation 
times (Fig. 3A, B). This observation is in accordance with 
two earlier studies showing cholesterol crystal growth in 
gallbladder bile samples with a CSI below 1.0. In a group 
of five patients with a CSI between 0.8 and 0.9, Schriever 
and Jiingst (22) observed cholesterol monohydrate 
crystals in gallbladder bile. Similar data were collected 
by Whiting and Watts (20), who determined the choles- 
terol solubility limit of human gallbladder bile by 
seeding bile samples with a small amount of cholesterol 
crystals. The reason for those findings is unclear but 
again demonstrates the limitations of the CSI in 
predicting cholesterol solubility in native bile. 
In accordance with our data van Erpecum et al. (13) 
found that bile concentration is inversely correlated 
with the CSI. A recent study by Shiffman, Sugerman 
and Moore (23) confirms this observation. In that study 
the CSI in gallbladder bile samples of 78 morbidly obese 
patients decreased curvilinearly from a maximum of 3.7 
in dilute bile to 1.0 to 1.5 in concentrated bile. In our 
study we did not find a significant effect of TLCs on 
cholesterol nucleation time. This is in accordance with 
the in uiuo and in uitro results of Gollish et al. (18) but 
contrary to the observations of van Erpecum et al. (13). 
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FIG. 3. Relation of TLC and CSI in gallbladder bile samples from 71 
patients with (A) solitary (0) (r = -0.38; p < 0.02) and 42 patients 
with (€3) multiple (0) cholesterol stones (r = -0.44; p < 0.02). 
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The use of ultrafiltration rather than ultracentrifu- 
gation in the study of van Erpecum et al. (13) before the 
nucleation assay might be responsible for these discrep- 
ancies. 
In conclusion, our data show a similar composition 
and concentration of biliary lipids in bile samples from 
patients with solitary vs. multiple cholesterol gallstones 
but a significant difference in the nucleation time. The 
rates of rapid nucleation (11 day) are similar to the 
percentage of long-term stone recurrence and suggest 
that rapid nucleation of cholesterol in gallbladder bile 
might be a major risk factor for recurrent cholesterol 
stones. 
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